SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ETON --3x FDA Decisions: July & October 2019 , May 2020
ETON 18.20-0.4%Oct 30 3:59 PM EDT
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: BioHero6/27/2019 2:03:57 PM
   of 16
 
First FDA decision in 3 Weeks for the drug below which is partnered with Bausch Health . If approved stock could run to $12-15 and higher especially with another FDA decision in sight (october 21 ) .

"If Approved, EM-100 Will Be the First OTC Preservative-Free Formulation of Its Kind

EM-100 Has Been Submitted to the FDA for Review"
ir.bauschhealth.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News